Spero Therapeutics
SPRO
$1.54
Share price
8.80%
Change (1 day)
-16.49%
Change (1 year)
Categories
Spero Therapeutics (SPRO) Fails to deliver data
Key failure to deliver metrics for Spero Therapeutics:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $0.06 M
- Last year FTD volume: $0.55 M
Failures to deliver for Spero Therapeutics (SPRO) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Spero Therapeutics (SPRO) - since 2017
Volume in USD (price x number of shares), data since 2017Spero Therapeutics (SPRO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.06 M | -91.85% |
| 2023 | $0.85 M | -88.65% |
| 2022 | $7.55 M | 81.02% |
| 2021 | $4.17 M | 23.57% |
| 2020 | $3.37 M | 2331.08% |
| 2019 | $0.13 M | -93.38% |
| 2018 | $2.09 M | -76.81% |
| 2017 | $9.04 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 IBM IBM | $0.21 B | $0.57 B | 🇺🇸 USA |
 Thomson Reuters
TRI | $70.85 M | $0.23 B | 🇨🇦 Canada |
 Franklin Covey FC | $0.08 M | $0.28 M | 🇺🇸 USA |